5 Years of Ocrelizumab in Relapsing Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Five Years of Ocrelizumab in Relapsing Multiple Sclerosis: OPERA Studies Open-Label Extension
Neurology 2020 Sep 29;95(13)e1854-e1867, SL Hauser, L Kappos, DL Arnold, A Bar-Or, B Brochet, RT Naismith, A Traboulsee, JS Wolinsky, S Belachew, H Koendgen, V Levesque, M Manfrini, F Model, S Hubeaux, L Mehta, X MontalbanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.